ADMA Shares Outstanding History
Below is a table of the ADMA shares outstanding history going back to 8/12/2013:

Date ADMA Shares Outstanding

Also see: ADMA Market Cap History
ADMA Historical Shares Outstanding:
+45.00% CAGR
ADMA Historical Shares Outstanding: +45.00% CAGR

Mouse over chart for data details
8/12/2013 ...11/1/2019
ADMA Biologics is a biopharmaceutical and immunoglobulin company that manufactures, markets and develops plasma-derived biologics for the treatment of immune deficiencies and the prevention and treatment of certain infectious diseases. Co.'s marketed products consist of: Nabi-HB, which is indicated for the treatment of acute exposure to blood containing Hepatitis B surface antigen; and Bivigam, which is indicated for the treatment of primary humoral immunodeficiency. Co. is also developing a pipeline of plasma-derived therapeutics, including its key pipeline product candidate, RI-002, for the treatment of Primary Immune Deficiency Disease. We show 27 historical shares outstanding datapoints in our coverage of ADMA's shares outstanding history.

Understanding the changing numbers of ADMA shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like ADMA versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching ADMA by allowing them to research ADMA shares outstanding history as well as any other stock in our coverage universe.
Quotes delayed 20 minutes
Get Free SEC filing alerts for ADMA:
ADMA SEC Filing Email Alerts ServiceExternal link
10 ETFs With Stocks That Insiders Are Buying
10 ETFs With Most Upside To Analyst Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Energy Stocks You Can Buy Cheaper Than Insiders Did
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active Call & Put Options of the S&P 500 Components
Video: Shares Outstanding Importance

If the video does not load after a few moments, Upgrade to the Latest Flash Player.
ADMA Biologics (ADMA) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:

ADMP Shares Outstanding History
ADMS Shares Outstanding History
ADPT Shares Outstanding History
ADRO Shares Outstanding History
ADUS Shares Outstanding History
ADVM Shares Outstanding History
ADXS Shares Outstanding History
AEMD Shares Outstanding History
AERI Shares Outstanding History
AEZS Shares Outstanding History
More Healthcare companies »


ADMA Shares Outstanding History | | Copyright © 2017 - 2020, All Rights Reserved

Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.